Chemical Weapons in the Iran-Iraq War (1980–1988) 3. Medical Consequences of Chemical Warfare
https://doi.org/10.35825/2587-5728-2019-3-3-255-289
EDN: utjrwz
Abstract
The third article in the series is dedicated to the medical consequences of the chemical warfare between Iran and Iraq during the war (1980–1988). The UN official documents and materials, declassified CIA documents, as well as other open Western and Iranian sources have been used during its preparation. The chemical war against the Islamic Republic of Iran was waged in the conditions of the increased power of chemical weapons, when the Iraqi army had the opportunity to carry out multiple massive chemical aviation strikes at operational depth and to use multiple launch rocket systems for the massive use of toxic substances in the tactical zone. The mortality from sulfur mustard reached 30 % in some sections of the front, that was impossible during the First World War. The unpreparedness of the Iranian army to chemical warfare led to the serious irretrievable losses among the Iranian military during the war (25 thousand people) and to the grave long-term consequences for the health of the survivors (at least 100 thousand people), despite of the relatively small amount of poisonous substances used by Iraq (2.54 thousand tons). As in World War I, sulfur mustard turned out to be the «king of gases» in this war. The Iranian scientists find out that even after the curing of acute lesions in hospitals the pathological process caused by the action of poisonous substances does not stop. It enters the phase of delayed effects, manifested with the age of the patient. There are the irreversible obstructive processes in the lungs («mustard lung»). In 2014 about 45 thousand Iranians suffered from late respiratory complications caused by sulfur mustard. There are the eczemoid dermatitis, vitiligo, psoriasis and discoid lupus erythematosus. There are the delayed ulcerative keratitis and various lesions in the neurological tissues of the eye and in the ocular fundus of the vascular system. There are other pathologies as well. The article contains a large number of photographs, diagrams and images, never published in Russian medical literature before.
Keywords
About the Authors
M. V. SupotnitskiyRussian Federation
Mikhail Vasilyevich Supotnitskiy. Senior Researcher. Chief Specialist. Candidate of Biological Sciences
Brigadirskii Lane 13, Moscow 105005
N. I. Shilo
Russian Federation
Natalya Igorevna Shilo. Researcher. Scientific Editor
Brigadirskii Lane 13, Moscow 105005
V. A. Kovtun
Russian Federation
Viktor Aleksandrovich Kovtun. Head of the Centre. Candidate of Chemical Sciences, Associate Professor
Brigadirskii Lane 13, Moscow 105005
References
1. Supotnitskiy M.V., Shilo N.I., Kovtun V.A. Chemical Weapons in the Iran-Iraq War (1980-1988). 1. Iraq Preparing for Chemical War // Journal of NBC Protection Corps. 2019. V. 3. № 1. P. 40–64 (in Russian).
2. Supotnitskiy M.V., Shilo N.I., Kovtun V.A. Chemical Weapons in the Iran-Iraq War (1980-1988). 2. Combat Use of Chemical Weapons // Journal of NBC Protection Corps. 2019. V. 3. № 2. P. 150–174 (in Russian).
3. Javed Ali. Chemical Weapons and the Iran-Iraq War: A Case Study in Noncompliance // The Nonproliferation Review/Spring. 2001. P. 43–58.
4. The Chemical Weapons Programme. United Nations Monitoring, Verification and Inspection Commission (UNMOVIC) Compendium. N.Y. 2001.
5. Razoux P. The Iran-Iraq War. Belknap Press: An Imprint of Harvard University Press, 2015.
6. Darchini-Maragheh E., Balali-Mood M. Delayed Complications and Long-term Management of Sulfur Mustard Poisoning: Recent Advances by Iranian Researchers (Part І of ІІ). Iran. J. Med. Sci. 2018. V. 43. № 2. P. 103–124.
7. Impact and implication of chemical weapons use in the Iran-Iraq war. Director Central Intelligence. Interagency Intelligence Memorandum. NI IIM 88-10004C. Top Secret. April 1988. Approved for release 08.10.2010.
8. Hashemian А., Khoshnood K., Desai M.M. et al. Anxiety, depression, and posttraumatic stress in Iranian survivors of chemical warfare // JAMA. 2006. V. 296. № 5. P. 560–566.
9. Razavi S.M., Karbakhsh M., Salamati P. Preventive measures against the mustard gas: a review // Medical J. Islamic Republic of Iran. 2013. V. 27. № 2. Р. 83–90.
10. Eghtedardoost M., Mohammad Z.H., Askari N. et al. The delayed effect of mustard gas on housekeeping gene expression in lung biopsy of chemical injuries // Biochem. Biophy. Reports. 2017. V. 11. P. 27–32.
11. Kovtun V.A., Golipad A.N., Melnikov A.V., Mosin N.I., Klimentyev Yu.A., Makarov M.L., Povalikhin A.P. Chemical Terrorism as a Coercive Instrument of Foreign Policy of the US and the West // Journal of NBC Protection Corps. 2017 V. 1 № 2 P. 3–13 (in Russian).
12. Kovtun V.А., Kolesnikov D.P., Supotnitskiy M.V., Shilo N.I. Syrian «Chemical War» // Journal of NBC Protection Corps. 2018 V. 2. № 3 P. 7–39 (in Russian).
13. Karami Ali. Long Legacy // CBRNe WORLD. 2012. August. P. 30–40.
14. Salamati P., Razavi S.M., Shokraneh F. et al. Mortality and injuries among Iranians in Iraq-Iran war: A systematic review // Arch. Iran Med. 2013. V. 16. № 9. Р. 542–550.
15. Urlanis, B.Ts. History of war losses. St. Petersburg: Poligon, 1994 (in Russian).
16. Krivoruchko А.P., Roschupkin V.Т. The Chief of Baghdad: rise and fall. The political portrait of Saddam Hussein. M., 2008 (in Russian).
17. Watson A.P., Griffin G.D. Toxicity of vesicant agents scheduled for destruction by the chemical stockpile disposal program // Environmental Health Perspectives. 1992. V. 98. P. 259–280.
18. Okumura T., Taki K., Suzuki K. et al. The Tokyo subway sarin attack: acute and delayed health effects in survivors // Handbook of Toxicology of Chemical Warfare Agents. Second Edition / Ed. Gupta R.C. Academic Press is an imprint of Elsevier. 2015. P. 27–35.
19. Kumura T., Suzuki K., Fukuda A. et al. The Tokyo Subway Sarin Attack: Disaster Management, Part 2: Hospital Response // Academic Emergency Medicine. 1998. V. 5. № 6. P. 618–624.
20. Balali-Mood M. Early and Delayed Effects of Sulfur Mustard in Iranian Veterans After the Iraq–Iran Conflict // In: Handbook of Toxicology of Chemical Warfare Agents. Second Edition / Ed. Gupta R.C. Academic Press is an imprint of Elsevier. 2015. P. 37–46.
21. Rajavi Z., Safi S., Javadi M.A. et al. Clinical practice guidelines for prevention, diagnosis and management of early and delayed‐onset ocular injuries due to mustard gas exposure // J. Ophthalmic. Vis. Res. 2017. V. 12. № 1. P. 65–80. https://doi.org/10.4103/jovr.jovr_253_16
22. Hefazi M., Maleki M., Mahmoudi M. et al. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16–20 years after exposure // Int. J. Dermatol. 2006. V. 45. P. 1025–1031.
23. Nohara M., Segawa K. Ocular symptoms due to organophosphorus gas (sarin) poisoning in Matsumoto // British J. Ophthalmology. 1996. V. 80. P. 1023–1027.
24. Razavi S.M., Razavi M.S., Pirhosseinloo M., Salamati P. Iraq-Iran chemical war: calendar, mortality and morbidity // Chinese J. Traumatology. 2014. V.17. № 3. P. 165– 169. https://doi.org/10.3760/cma.j.issn.1008-1275.2014.03.008
25. Ghabili K., Agutter P.S., Ghanei M. et al. Mustard gas toxicity: the acute and chronic pathological effects // J. Appl. Toxicol. 2010. V. 30. P. 627–643. https://doi.org/10.1002/jat.1581
26. Shakarjian M.P, Heck D.E, Gray J.P et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure // Toxicological Sciences. 2010. V. 114. P. 5–19.
27. Calabresi P., Chabner B. Antineoplastic Agents // In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics / Eds. Gilman A., Rall T., Nies A., Taylor P. New York: McGraw-Hill, 1990. Р. 1209–1219.
28. Khlopin G.V. Basic Military and Sanitary Principles of Chemical Defence. Мoscow, 1930.
29. Franke S. Lehrbuch der Militärchemie. Band 1. Deutscher Militärverlag. Berlin. 1967.
30. De-Lazari A.N. Chemical weapons on the fronts of the World War 1914-1918: A brief historical essay / Sci. Ed. Supotnitskiy M.V. Moscow, 2008 (in Russian).
31. Notes on German shells (second edition). General Staff (Intelligence), General Headquartens, Ist May, 1918. London. 1918.
32. Mayer Yu. Chemical agents and their combat use. Part II. Мoscow, 1928 (in Russian).
33. Mayer Yu. Chemical agents and their combat use. Part I. Мoscow, 1927 (in Russian).
34. Foroutan S.A. Medical notes on chemical warfare, part II // Kowsar. Med. J. 1997. V. 1. P. 159–177 [in Persian].
35. Balali-Mood M., Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans // Basic Clin. Pharmacology Toxicology. 2006. V. 99. P. 273–282.
36. Edere Ch., Easten М. Chemical Weapons and Their Toxic Effects. Moscow, 1939 (in Russian).
37. Karakchiev N.I. Toxicology and WMD protection. Tashkent, 1973 (in Russian).
38. Freitag L., Firusian N., Stamatis G., Greschuchna D. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation // Chest. 1991. V. 100. P. 1436–1441.
39. Razavi M.S, Salamati P., Saghafinia M., Abdollahi M. A review on delayed toxic effects of sulfur mustard in Iranian veterans // Daru. 2012. V. 20. P. 51. https://doi.org/10.1186/2008-2231-20-51
40. Firoozabadi M.D., Sheikhi M.F. Rahmani H. et al. Risks of on-pump coronary artery bypass grafting surgery in patients with chronic obstructive pulmonary disease due to sulfur mustard // Postep. Derm. Alergol. 2017. V. 5, № 5. P. 429–432. https://doi.org/10.5114/ada.2017.71107
41. Emad A., Rezaian G.R. The diversity of effects of sulfur mustard gas inhalation on respiratory system 10 years after a single heavy exposure: analysis of 197 cases // Chest. 1997. V. 112. P. 734–738.
42. Le H.Q., Knudsen S.J. Exposure to a First World War blistering agent // Emerg. Med. J. 2006. V. 23. P. 296–299.
43. Willems J.L. Clinical management of mustard gas casualties // Ann. Med. Milit Belg. 1989. 3s:14, 15.
44. Willems J.L. Clinical management of mustard gas casualties. Heymans Institute of Pharmacology University of Ghent Medical School, Royal School of the Medical Services Leopoldskazerne. Belgium. Ghent, 1989.
45. Shahriar K. Victims of Chemical Weapons in Iran. Society for Chemical Weapons Victims Support. Tehran. 2005.
46. Balali-Mood M., Navaeian A. Clinical and paraclinical findings in 233 patients with sulphur mustard poisoning // In: Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare / Ed. Heyndrickx B. Rijksuniversiteit: Ghent. 1986. P. 464–473.
47. Balali-Mood M., Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning // Fundam. Clin. Pharmacol. 2005. V. 19. P. 297–315.
48. Tianyi Gu. Mechanism and treatment of sulfur mustard-induced cutaneous injury // Chinese J. Traumatology. 2014. V. 17. № 6. P. 345–350. https://doi.org/10.3760/cma.j.issn.1008-1275.2014.06.010
49. Ghasemi H., Ghazanfari T., Ghassemi-Broumand M. et al. Long-term ocular consequences of sulfur mustard in seriously eye-injured war veterans // Cutan. Ocul. Toxicol. 2009. V. 28. P. 71–77.
50. Darchini-Maragheh E., Abrishami M., Moshiri M. et al. Longterm complications of sulphur mustard poisoning: Ocular electrophysiological assessment in 40 Iranian veterans / Ed. Balali-Mood M. 12th Iranian Congress of Toxicology. 2013. May 15–17. Sari, Iran.
51. Balali-Mood M., Balali-Mood B. Sulphur mustard poisoning and its complications in Iranian veterans // Iran J. Med. Sci. 2009. V. 34. P. 155–171.
52. Shoeibi N., Balali-Mood M., Abrishami M. Sulfur mustard exposure and non-ischemic central retinal vein occlusion // Iran J. Med. Sci. 2016. V. 41. P. 59–63.
53. Karbasi-Afshar R. Mohammadifard M., Azdaki N. et al. Sulfur mustard exposure and cardiovascular effects: a review // Trauma. Mon. 2017. V. 22. https://doi.org/10.5812/ traumamon.34011
54. Darvishi B., Panahi Y., Ghanei M., Farahmand L. Investigating prevalence and pattern of long-term cardiovascular disorders in sulphur mustard-exposed victims and determining proper biomarkers for early defining, monitoring and analysis of patients’ feedback on therapy // Basic Clin. Pharmacology Toxicology. 2017. V. 120. P. 120–130. https://doi.org/10.1111/bcpt.12666
55. Panahi Y., Ghanei M., Ghabili K. et al. Acute and chronic pathological effects of sulfur mustard on genitourinary system and male fertility // Urology J. 2013. V. 10. P. 837–846.
56. Ahmadi K., Ranjebar-Shayan H., Rezazade M., Ahmadizadeh M-J. Sexual dysfunction among combat veterans injured by chemical warfare // Int. J. Sex. Health. 2014. V. 26. P. 93–99.
57. Harchegani А., Niha M., Milad M. et al. Cellular and molecular mechanisms of sulfur mustard toxicity on spermatozoa and male fertility // Toxicol. Res. 2018. V. 7. P. 1029–1035. https://doi.org/10.1039/c8tx00062j
58. Medical aspects of Chemical Warfare / Eds. Tuorinsky S.D., Lenhart M.K. Walter Reed Army Medical Center. Washington. 2008.
59. Vayle S.S., Pozhariysky F.I. Pathological anatomy of warfare gases exposures. Мoscow, 1940 (in Russian).
Review
For citations:
Supotnitskiy M.V., Shilo N.I., Kovtun V.A. Chemical Weapons in the Iran-Iraq War (1980–1988) 3. Medical Consequences of Chemical Warfare. Journal of NBC Protection Corps. 2019;3(3):255-288. (In Russ.) https://doi.org/10.35825/2587-5728-2019-3-3-255-289. EDN: utjrwz